Starpharma Holdings Limited operates within the Commercial physical research sector. In addition to historical fundamental analyses, the complete report available to purchase compares Starpharma Holdings Limited with three other companies in this sector in AUSTRALIA : Cellmid Limited (2020 sales of 7.48 million Australian Dollars [US$5.82 million] of which 79% was Advangen Japan), Medlab Clinical Ltd (5.37 million Australian Dollars [US$4.18 million] of which 67% was Pharmaceutical Research), and Holista Colltech Limited (7.13 million Australian Dollars [US$5.55 million] ).

Sales Analysis. Sales increased substantially in 2020: During the year ended June of 2020, sales at Starpharma Holdings Limited were A$7.12 million (US$5.54 million). This is an increase of 161.6% versus 2019, when the company's sales were A$2.72 million.